Aurobindo Pharma's Eugia Pharma approved to manufacture Dasatinib Tablets, a bioequivalent to Bristol-Myers Squibb's Sprycel, ...

The Nifty Midcap index closed 1.18 percent higher at 55,041, while Nifty Smallcap index ended the session with marginal gains ...

Tractor delivery momentum is expected to continue in Q1FY26 on expectation of very good Rabi crop harvest and improved cash ...

Examine the best colleges in India offering Pharma courses as per NIRF Rankings, along with courses offered, seat intake, ...

After a consistent five-day rally, the market may consolidate, though the overall trend remains positive. Below are some ...

India supplies over 45% of the generics and 15% of biosimilars used in the U.S., with major companies like Dr. Reddy’s, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma, and Gland Pharma earning ...

The Board of Directors of HDFC Life Insurance Company Limited at their meeting held today i.e. Thursday, April 17, 2025, has ...

The United States District Court for the District of Delaware has passed an order against Lupin Ltd in the matter of Myrbetriq® patent case.

Key stocks to watch on April 15 are shares of Swiggy, HCLTech, Dr Reddy, Tata Power, IREDA ICICI Lombard, ICICI Pru Life, ...

Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has issued 11 observations after an inspection at Raleigh Plant, North Carolina, USA, owned by ...